Veeva Systems Inc.

Veeva Systems Inc.

VEEV
Veeva Systems Inc.US flagNew York Stock Exchange
264.21
USD
-0.69
- -
42.92BMarket Cap
Veeva Systems Inc.
VEEV
(New York Stock Exchange)

Recent

price

264.21

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
0.28
0.56
1.19
4.06
2.45
3.1
4.06
4.92
5.98
7.47
9.72
12.08
13.87
14.72
16.97
19.52
21.15
Revenue per Share
0.04
0.04
0.17
0.46
0.32
0.41
0.57
1.08
1.59
2.04
2.52
2.79
3.14
3.27
4.41
5.55
6.21
Basic EPS, GAAP
0.04
0.03
0.27
0.75
0.32
0.44
1.01
1.6
2.1
2.94
3.66
4.99
5.02
5.68
6.73
8.65
10.19
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
0.06
0.22
2.24
3.1
3.78
4.73
6.38
8.47
11.17
14.9
18.88
23.48
28.8
35.87
44.05
45.92
Book Value per Share
- -
0.05
0.21
2.14
3.02
2.71
3.75
5.48
7.64
7.33
11.28
15.37
20.18
25.68
32.89
41.18
42.53
Tangible Book Value per Share
106
108
108
52
128
132
136
140
144
148
151
153
155
161
162
164
164
Basic Weighted Avg Shares
29
61
130
210
313
409
551
691
862
1,104
1,465
1,851
2,155
2,364
2,747
3,195
3,458
Sales/Revenue/Turnover
17.48
10.84
23.18
18.7
22.34
19.2
21.92
22.87
25.85
25.92
25.79
27.31
21.3
18.16
25.17
28.68
29.93
Operating Margin (%)
- -
- -
1
2
4
8
14
14
14
20
29
27
29
33
39
38
40
Depreciation Expense
4
4
19
24
40
54
78
151
230
301
380
427
488
526
714
909
1,015
Net Income, GAAP
25.74
36.42
35.44
38.66
39.89
30.73
36.6
8.8
3.69
4.01
3.55
16.58
4.2
10.6
22.32
23.91
23.55
Effective Tax Rate (%)
13.42
6.9
14.5
11.24
12.89
13.31
14.09
21.89
26.66
27.27
25.94
23.09
22.63
22.24
26
28.44
29.34
Profit Margin (%)
- -
13
33
267
366
315
465
706
1,032
980
1,595
2,266
2,963
3,824
4,910
6,361
6,490
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
45
51
44
50
46
66
84
137
LT Debt
- -
14
34
280
407
505
653
906
1,238
1,666
2,266
2,912
3,716
4,645
5,832
7,215
7,431
Total Equity
- -
61.15
73.66
14.98
12.11
11.86
13.14
18.36
19.92
18.47
17.88
15.8
12.94
8.99
10.09
10.54
11.05
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
117.99
109.83
15.38
11.76
11.94
13.4
19.4
21.44
20.74
19.33
16.51
14.72
12.58
13.63
13.93
14.42
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
Jan'26
Apr'27
Jul'27
ST Debt
12
13
15
LT Borrowings
- -
- -
- -
LT Finance Leases
84
90
137
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
164
163
162
Market Capitalization
33,398
25,414
32,979

Working Capital

FRC

in mil. unless spec.
Jan'26
Apr'27
Jul'27
Total Current Assets
7,998
8,063
7,946
Cash, Cash Equivalents & STI
6,561
7,313
7,243
Accounts Receivable, Net
1,260
568
497
Inventories
- -
- -
- -
Total Current Liabilities
1,637
1,702
1,456
Payables & Accruals
90
160
89
ST Debt
12
13
15
Deferred Revenue
1,489
1,477
1,310

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
30.56%
26.07%
23.7%
Free Cash Flow
41.05%
21.4%
29.83%
Net Income, GAAP
34.41%
19.5%
27.27%
Sales/Revenue/Turnover
23.06%
17%
16.34%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
650
676
699
721
2,747
2026
759
789
811
836
3,195
2027
883
928
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
1
1.06
1.15
1.2
4.41
2026
1.4
1.23
1.44
1.49
5.55
2027
1.6
1.68
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -
Business
Veeva Systems Inc. (NYSE: VEEV) provides cloud-based software solutions, data, and services for the global life sciences industry, spanning research and development through commercialization; its core offerings include the Veeva Vault Platform with applications for clinical operations such as Vault EDC and Vault CDMS, regulatory management, quality processes via Veeva QualityOne, safety and pharmacovigilance, medical affairs, and commercial functions through Veeva CRM and the transitioning Vault CRM suite; additional solutions cover customer master data management, content management, and AI-enhanced tools like Veeva AI Agents. Veeva operates as a public benefit corporation headquartered in Pleasanton, California, with offices across North America, Europe, Asia, and Latin America, serving over 1,000 customers from large biopharmaceutical firms to emerging biotechs. Founded in 2007, the company targets regulated industries including pharmaceuticals, biotechnology, MedTech, and expansions into consumer goods, cosmetics, and chemicals. Recent developments include the October 2024 strategic partnership with Walgreens to enrich Veeva Data Cloud and enhance patient outcomes through integrated access to Veeva Clinical Platform; an expanded collaboration with Roche announced November 24, 2025; a partnership with Amgen in August 2025 to advance clinical trial innovation; the launch of Vault CRM in 2024 as a next-generation CRM migrating from Salesforce to Veeva's Vault platform, with new modules like Vault CRM Service Center and forthcoming Vault CRM Bot using generative AI; and the December 2025 availability of Veeva AI Agents to boost productivity.

Company News

  • Empresa líder en biotecnología selecciona Veeva Vault CRM a nivel mundial

  • Veeva Systems (VEEV) Just Flashed Golden Cross Signal: Do You Buy?

  • Leading Biotech Selects Veeva Vault CRM Globally

  • Veeva Systems Sees AI as Growth Engine Beyond Its $6B 2030 Revenue Target

  • Veeva Systems Unveils Falcon AI as Commercial Growth Gains Momentum

  • Veeva Systems Inc. (VEEV) Presents at Citi's 2026 Global TMT Conference Transcript

  • Why Veeva Systems (VEEV) is a Top Momentum Stock for the Long-Term

  • California State Teachers Retirement System Acquires 39,152,230 Shares of Veeva Systems Inc. $VEEV

  • HB Wealth Management LLC Sells 3,313 Shares of Veeva Systems Inc. $VEEV

  • Veeva Systems Inc. (VEEV) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

  • Does iShares Pharma ETF Offer Superior Returns to Invesco's Equal Weight Healthcare Fund?

  • Brown Lisle Cummings Inc. Lowers Stock Holdings in Veeva Systems Inc. $VEEV

  • Why Veeva Systems (VEEV) is a Top Growth Stock for the Long-Term

  • VEEV Raises FY27 Outlook as Vault CRM and AI Momentum Accelerate Fast

  • Reasons to Hold Veeva Systems Stock in Your Portfolio for Now

  • The Market Just Told You Which Layer Of AI Biology It Is Paying For

  • Michael Burry Sends Fresh Warning on Surging Tech Stock

  • Veeva's Exiting President Sold $2.8 Million in Stock: What Investors Need to Know

  • Veeva to Present at Upcoming Investor Conferences

  • Veeva Rises on Sales and Margin Gains, Guidance Raise